Kineta Inc. (NASDAQ: KA) Stock Information | RedChip

Kineta Inc. (NASDAQ: KA) Listen to this Section


$0.56
-0.0189 ( -3.25% ) 31.0K

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Market Data


Open


$0.56

Previous close


$0.58

Volume


31.0K

Market cap


$6.92M

Day range


$0.58 - $0.64

52 week range


$0.33 - $5.39

Insider Ownership Transactions

Total Amount Purchased: -1,793,538.00 | $ -1,009,761.89

Date Type Amount Purchased Purchaser
2024-05-02 Sale -903995.00 Bartoszek Raymond J.
2024-04-16 Sale -225000.00 Guillaudeux Thierry
2024-04-16 Sale -225000.00 Baker Keith
2024-04-16 Sale -225000.00 PHILIPS CRAIG W.
2024-04-16 Sale -225000.00 Iadonato Shawn
2023-12-06 Buy 1000.00 Bartoszek Raymond J.
2023-11-30 Buy 900.00 Iadonato Shawn
2023-11-30 Buy 3000.00 PHILIPS CRAIG W.
2023-10-12 Sale -4443.00 Foote Marion R
2023-09-21 Buy 10000.00 Iadonato Shawn

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 76 Aug 08, 2024
8-k 8K-related 14 Jul 08, 2024
8-k 8K-related 11 Jun 25, 2024
8-k 8K-related 11 May 30, 2024
8-k 8K-related 13 May 15, 2024
10-q Quarterly Reports 75 May 15, 2024
4 Insider transactions 1 May 02, 2024
ars Annual reports 1 Apr 26, 2024
def Proxies and info statements 7 Apr 26, 2024
8-k 8K-related 12 Apr 24, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.